Cipla (BOM:500087) Accounts Payable & Accrued Expense : ₹29,142 Mil (As of Mar. 2025)

View and export this data going back to 1992. Start your Free Trial

What is Cipla Accounts Payable & Accrued Expense?

Cipla's quarterly accounts payable & accrued expense declined from Sep. 2024 (₹28,220 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹29,142 Mil).

Cipla's annual accounts payable & accrued expense increased from Mar. 2023 (₹30,444 Mil) to Mar. 2024 (₹30,853 Mil) but then declined from Mar. 2024 (₹30,853 Mil) to Mar. 2025 (₹29,142 Mil).

Cipla Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cipla's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipla Accounts Payable & Accrued Expense Chart

Cipla Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

25,064.50

29,713.00

30,443.80

30,852.60

29,142.40

Cipla Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															30,852.60	-	28,220.00	-	29,142.40

Cipla Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cipla Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipla Ltd (BOM:500087) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

CIPLA:India

Address

Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013

Website

https://www.cipla.com

Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

Cipla Headlines

No Headlines